This document discusses female urethral diverticula (UD). It defines UD as urine-filled cysts connected to the urethra. UD can cause a range of symptoms from asymptomatic to severe pain. The document discusses the anatomy of the female urethra and theories on the pathophysiology and etiology of UD. It describes the variability in presentation of UD and evaluations used for diagnosis including physical exam, imaging like VCUG, and cystoscopy. The document also covers differential diagnosis, indications for surgical repair, techniques for repair like excision and reconstruction, and potential postoperative complications.
Urinary Tract Fistulas -(VVF) Etiology, Diagnosis, ManagementVikas V
Urinary Tract Fistulas - Etiology, Diagnosis, Management
Surgical and Relevant Anatomy, Classification, eitiology, VVF in Detail, Examination and Diagnosis, Management of VVF - Both Conservative And Surgical Management - Steps of Surgical Management, Post operative Management.
Urinary Tract Fistulas -(VVF) Etiology, Diagnosis, ManagementVikas V
Urinary Tract Fistulas - Etiology, Diagnosis, Management
Surgical and Relevant Anatomy, Classification, eitiology, VVF in Detail, Examination and Diagnosis, Management of VVF - Both Conservative And Surgical Management - Steps of Surgical Management, Post operative Management.
Anomalies of the Gastrointestinal Tract and Anterior Abdominal.ppthendra472440
suatu materi tentang kelainan anatomi sistem pencernan yg berhubungan dengan obstertri dan ginekologi. termasuk lambung, usus halus, usus besar, rektum dan anus. Dapat berguna untuk penapisan sebelum bayi lahir. Diharapkan dengan materi ini dapat meningkatkan pengetahuan mahasiswa dalam ilmu yang berkaitan dengan Gastrointestinal terpadu. digunakan pada masyarakat umum dan sekitarnya.
Presentation Topic: Endometriosis. Discuss in detail the endometriosis . What is it? What is the etiology, clinical features, how can you diagnose and what is it's treatment as well as management. You'll find everything in this presentation along with pictures and illustrations.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
2. Definition
Urethral diverticula(UD) in female patients are variably
sized, urine-filled periurethral cystic structures adjacent to
the urethra within the confines of the pelvic fascia,
connected to the urethra via an ostium.
Completely asymptomatic, incidentally noted lesions on
physical examination or imaging, to very debilitating
conditions like painful vaginal masses associated with
incontinence, stones, severe dyspareunia, and/or tumors.
3. Anatomy of the Female Urethra
A musculofascial tube approximately 3 to 4 cm in
length,
extending from the bladder neck to the external urethral
meatus,
suspended from the pelvic sidewall and pelvic fascia
(tendinous arc of the obturator muscle) by a sheet of
connective tissue known as the urethropelvic ligament.
4. Urethropelvic ligament
An abdominal side (the endopelvic fascia)
A vaginal side (the periurethral fascia).
Within and between these two leaves of fascia lie the
urethra and the location of most UD.
5. Within the thick, vascular lamina propria/ submucosal layer
are the periurethral glands.
These tubuloalveolar glands exist over the entire length of
the urethra posterolaterally; however, they are most
prominent over the distal two-thirds.
It is from pathological processes
involving the periurethral glands
that most acquired female UD are
thought to originate.
6. The urethra has several muscular layers: an internal
longitudinal smooth muscle layer, an outer circular smooth
muscle layer, and a skeletal muscle layer.
The skeletal muscle component
spans much of the length of the
urethra but is more prominent in
the middle third.
It has a U-shaped configuration,
deficient dorsally.
The location and competence of the urethral sphincters have
important implications when considering surgical repair of
UD because of the anatomic overlap of these two entities.
7. Pathophysiology and Etiology
As conceptualized by Young and Wahle (1996), UD
represent a cavity dissecting within the confines of the
fascia of the urethropelvic ligament.
This defect is often an isolated cyst like appendage with
a single discrete connection to the urethral lumen known
as the neck or ostium.
However complicated anatomic patterns may exist,
o Saddlebag UD
o Circumferential UD
9. The exact origin of UD is still unproven, whether UD were
congenital or acquired lesions??
The vast majority of UD, however, are classified as
acquired and are diagnosed in adult females.
There are multiple theories regarding the formation of
acquired UD.
The result of trauma from vaginal childbirth (McNally,
1935) ── an old concept
Pathophysiology and Etiology
10. The periurethral glands are thought to be the probable site of
origin of acquired UD (Young and Wahle, 1996).
What are these periurethral glands ??
As located primarily dorsolateral
to the urethra, arborizing proximally
along the urethra and draining into
ducts located in the distal one-third
of the urethra
Pathophysiology and Etiology
11. Infection of the periurethral glands seems to the most
generally accepted common etiologic factor in most cases.
Recurrent infection of the periurethral glands, with
obstruction, suburethral abscess formation, and subsequent
rupture of these infected glands into the urethral lumen.
Reinfection, inflammation, and recurrent obstruction of the
neck of the cavity are theorized to result in patient symptoms
and enlargement of the diverticulum.
Pathophysiology and Etiology
12. This expansion occurs most commonly ventrally, resulting
in the classic anterior vaginal wall mass palpated on physical
examination in some patients with UD.
Eventually, the abscess cavity ruptures into the urethral
lumen, resulting in the communication between the UD and
the urethral lumen.
Pathophysiology and Etiology
13. Prevalence
The true prevalence of female UD, however, is not
known; it is reported to occur in up to 1% to 6% of adult
females in some series.
14. Diverticular Anatomy and Histology
The interior surface of UD may be urothelial, squamous,
columnar, or cuboidal epithelium, or mixed
Most UD demonstrate benign histopathology, but
premalignant and malignant changes can be seen.
Approximately 10% of urethral diverticulectomy specimens
may demonstrate significant histopathologic abnormalities,
including metaplasia, dysplasia, or frank carcinoma, which
require long-term follow-up or additional therapy
15. The most common malignant pathology in UD is
adenocarcinoma, followed by urothelial cell and squamous
cell carcinomas.
Calculi within UD are not uncommon and may be
diagnosed in 4% to 10% of cases.
16.
17. Presentation
The majority of patients with UD are seen initially
between the third and seventh decades of life.
The classic presentation of UD has been described
historically as the “three Ds”—dysuria, dyspareunia and
dribbling (postvoid) ── 5% only
Now variable presentation with the most
common symptoms are irritative lower LUTS(e.g.,
frequency, urgency), pain, and infection.
18. Presentation
Dyspareunia in 12% to 24% of patients
Postvoid dribbling in 5 to 32%
Recurrent cystitis or UTI 30% to 46%
Other complaints include
o pain,
o a vaginal mass, hematuria, vaginal discharge,
obstructive symptoms,
o or urinary retention.
Notably, up to 10% to 20% of patients diagnosed
with UD may be completely asymptomatic, having the
lesions diagnosed incidentally on imaging or physical
examination
19. Evaluation and Diagnosis
The diagnosis of UD can be made with a combination of a
thorough
History and physical examination,
Appropriate urine studies (including urine culture and
analysis),
Endoscopic examination of the bladder and urethra, and
Selected radiologic imaging.
A urodynamic study may also be helpful in completing
the evaluation in selected cases
20. History and physical examination
Lower urinary tract symptoms, hematuria
Prior diagnostic studies,
Prior pelvic surgery, esp. incontinence procedures;
(bulking agents, use of sling procedures etc)
Urinary incontinence and type ?
Sexual function and
Dyspareunia
21. Exammination
The anterior vaginal wall should be carefully palpated
for masses and tenderness.
The location, size and consistency of any suspected
UD should be recorded.
Gently “stripped” or “milked” urethra distally
The vaginal walls are assessed for atrophy, rugation,
and elasticity.
The distal vagina and vaginal introitus are also
assessed for capacity.
Provocative measures to elicit incontinence and
presence or absence of prolapse
22. Urine Studies
Urine analysis and culture should be performed.
E. Coli most common
Urine cytology ── suspect malignancy
Cystourethroscopy :
o CPE is performed in an attempt to visualize the UD
ostium as well as to evaluate for other causes for the
patient’s lower urinary tract symptoms.
o The UD ostium is most often located posterolaterally at
the 4 and 8 o’clock positions at level of the mid-urethra
23. Urodynamics:
Approximately one-third of women with UD are seen
initially with symptoms of urinary incontinence, and up to
50% of women with UD demonstrate SUI on urodynamic
evaluation
24. Imaging
Currently available techniques for the evaluation of UD
include :
Double-balloon PPU,
VCUG,
Intravenous urography ,
Ultrasonography and
MRI with or without an endoluminal coil.
25. Double-balloon PPU
A highly specialized catheter (Trattner catheter) with
two balloons separated by several centimeters .
No need for patient
voiding
Not widely
used clinically
26. VCUG
Widely available and is a familiar diagnostic technique
to most radiologists.
Limitations:
Invasive,
Painful
Must void to image
UD ostia must be patent to
image
Poor stream will underestimate
size, loculations(?)
27. Intravenous Urography or CT urogram
Intravenous urography or CT urogram may be
considered in patients in whom it is necessary to delineate
the upper urinary tract
or
To evaluate for the possibility of a congenital ectopic
ureteral anomaly as the cause of an anterior vaginal wall
mass
28. Ultrasonography
Abdominal, transvaginal, translabial and transurethral
techniques have been described.
Transvaginal imaging often provides information
regarding the size and location of UD.
The UD appears as an anechoic or hypoechoic area with
enhanced through-transmission.
However the limitations are operator dependent and
images lack precise “surgical anatomy”
29. Magnetic Resonance Imaging
UD appear as areas of decreased signal intensity on T1
images compared with the surrounding soft tissues and
have high signal intensity on T2 images.
Surface coil MRI and eMRI appear to be superior to
VCUG and/or PPU in the evaluation of UD
30. Differential Diagnosis: Periurethral Masses
Vaginal Leiomyoma.
freely mobile, firm, nontender
masses on the anterior vaginal
wall.
fourth to fifth decade.
Excision or enucleation
31. Skene Gland Abnormalities.
Skene gland cysts and Abscesses
Small, cystic masses
Just lateral or inferolateral
to the urethral meatus
Extremely tender and
inflamed
No communication
Young to middle-age
female patients
32. Gartner Duct Abnormalities.
Mesonephric remnants and are found on
the anterolateral vaginal wall from the cervix to
the introitus.
They may drain ectopic ureters
from poorly functioning or
nonfunctioning upper pole
moieties
Upper tract evaluation
is recommended
33. Vaginal Wall Cysts.
The derivation of the cyst was mullerian in 44%,
epidermoid in 23%, and mesonephric in 11%.
Multiple cell types:
o Mesonephric (Gartner duct cysts),
o Paramesonephric (mullerian),
o Endometriotic,
o Urothelial, or
o Epidermoid (inclusion cyst).
Postmenopausal women and
prepubertal girls
34. Urethral Caruncle
An inflammatory lesion of the distal urethra
Postmenopausal women
Reddish exophytic mass at
the urethral meatus
Etiologically, they are
related to mucosal prolapse
Consevative Mx and in rare
case need excision
35. Periurethral Bulking Agents.
The transurethral or periurethral injection of bulking
agents for the treatment of stress incontinence may result
in an anterior vaginal wall mass that appears cystic on
imaging, consistent with a UD.
36.
37. Urethral Diverticula and Stress Urinary
Incontinence
7% and 16%
Risk factors for de novo SUI may include
o The size of the diverticulum (>30 mm),
o More proximal location and
o Circumferential configuration
A concomitant anti-incontinence surgery can be offered
Synthetic materials (e.g., mid-urethral polypropylene mesh)
should not be used
Autologous pubovaginal fascial slings provide satisfactory
outcomes
38. Surgical Repair of Female Urethral
Diverticula
Indications for Repair
Symptomatic patients, including those with dysuria,
refractory bothersome postvoid dribbling, recurrent UTIs,
dyspareunia, and pelvic pain, may be offered surgical
excision.
39. Techniques for Repair
Approaches include
Transurethral marsupialization (Davis et al., 1970) and
open marsupialization ( Spence and Duckett, 1970)
Endoscopic unroofing (Spencer and Streem, 1987),
Fulguration (Saito, 2000),
Incision and obliteration with oxidized cellulose
(Ellick,1957)
Excision of UD with reconstruction
41. Preoperative Preparation.
Prophylactic antibiotics
Application of topical estrogen creams for several weeks
before surgery may be beneficial in postmenopausal atrophic
vaginitis.
Video-urodynamics can often accurately differentiate and
characterize true SUI from postvoid dribbling, vaginal
voiding, and false incontinence resulting from urine
discharge from a urine-filled UD.
42.
43. Postoperative Care.
Antibiotics are continued for 24 hours postoperatively.
The vaginal packing is removed and the patient
discharged home with closed urinary drainage.
Antispasmodics are used liberally to reduce bladder
spasms.
A pericatheter VCUG is obtained at 14 to 21 days
postoperatively.
If there is no extravasation, the catheters are removed.
44. Complications
Overall, common complications include recurrent UTIs,
urinary incontinence, or recurrent UD
Urethrovaginal fistula is an uncommon but distressing
complication.
Most UD are located ventrally over the middle and proximal portions of the urethra, corresponding to the area of the anterior vaginal
wall 1 to 3 cm inside the introitus
Tender vaginal mass in 30%
Poorly estrogenized, atrophic tissues are important to note if surgery is being considered for definitive treatment.
Medical treatment involves topical creams (estrogen, anti-inflammatory) and/or sitz baths. Various surgical techniques have been described, including cauterization, ligation around a Foley catheter, and complete circumferential excision.